Delivery Order SPE2DB22D2206-SPE2DB24FEN62
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $5,818.38 firm fixed-price delivery order is for the supply of Spiriva Respimat 1.25 MCG inhalation medication, which is used to treat chronic obstructive pulmonary disease (COPD). The contract has an ultimate completion date of January 16, 2024 and was awarded on January 12, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract...
- This federal contract award, valued at $5,749.23, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Spiriva Respimat 2.5 MCG INH 4GM, a prescription medication used to treat chronic obstructive pulmonary disease (COPD). The award is a delivery order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, which Cencora, Inc. holds with the DLA Troop Support Medical. This IDC...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of SPIRIVA RESPIMAT 1.25 MCG INH 4GM pharmaceutical products. The $1,148.01 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for...
- This federal contract award, valued at $1,177.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of Spiriva Respimat 1.25 MCG INH 4GM, a pharmaceutical product used for respiratory conditions. The contract is a Firm Fixed Price Delivery Order with a completion date of July 19, 2023. The award was made through full and open competition, with no set-aside designation. Amerisourcebergen Drug Corp holds a...
- This federal contract award, valued at $3,391.06, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Spiriva Respimat 2.5 mcg inhalation medication in 4 gram units. The contract has no set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $12,081.53 firm fixed price delivery order is for the supply of Spiriva Respimat 2.5 mcg 60 counts, a medication used to treat chronic obstructive pulmonary disease (COPD). The contract has an ultimate completion date of August 14, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SPIRIVA RESPIMAT 1.25 MCG INH 4GM, a medication used to treat chronic obstructive pulmonary disease (COPD). The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,042.65 and a period of performance through July 11, 2025. The contract is not set-aside and is open to...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to supply Spiriva Respimat 2.5 MCG inhalation medication. The $1,225.51 firm fixed-price delivery order has a completion date of May 18, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. The IDC serves...
- This federal contract award, valued at $1,313.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Spiriva Respimat 2.5 mcg inhalation medication, a pharmaceutical product used to treat respiratory conditions. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, which Cencora, Inc. holds with the DLA Troop Support Medical....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,348.16, is for the delivery of Spiriva Respimat 2.5 MCG INH 4GM, a respiratory medication. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FEN62Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The $1,477.15 contract is for the delivery of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a medication used to treat chronic obstructive pulmonary disease (COPD). The contract has an ultimate completion date of December 11, 2023 and utilizes a firm fixed price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical division. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities and veterans' healthcare programs worldwide. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 12/8/23 |